Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 July 2022 | Story André Damons | Photo André Damons
UFS Traditional Medicine
Recardia Schoeman, Scientific Officer in the Department of Pharmacology, gave Prof Paul Waako, Dr Samuel Baker Obakiro, and Dr Richard Oriko Owor from the Busitema University a tour of the department and its laboratories.

Prof Motlalepula Matsabisa, Director of Pharmacology at the University of the Free State (UFS), played host to academics from the Busitema University in Uganda for benchmarking on traditional medicine and to establish collaboration between the two institutions.

Prof Paul Waako, Vice-Chancellor of the Busitema University – who was part of the visiting party – and Prof Francis Petersen, UFS Rector and Vice-Chancellor, signed a collaboration agreement that enables the two institutions to work together and to get involved in the exchange of expertise as part of the collaboration.

Dr Samuel Baker Obakiro, Lecturer of Pharmacology and Therapeutics and Head of the Department of Pharmacology, and Dr Richard  Oriko Owor, a natural products chemist, accompanied Prof Waako on the visit to the UFS from 18 to 21 July, during which they undertook tours of various departments and laboratories, including Pharmacology, Virology, Chemistry, Genetics, Physics, Microbiology, and others. They also visited FARMOVS.

 

Establishing collaboration

Uganda – through their Ministry of Science, Technology, and Innovation – has a national drive to ensure that science contributes to socio-economic development through their major national agenda, which promotes local production, reduces importation, and increases exportation of goods. Dr Monica Musenero Masanza, Minister of Science, Technology, and Innovation, wants to ensure that the capacity of Ugandan scientists to conduct applied research will promote national development and reduce poverty.

Prof Waako said they came to the UFS to establish collaboration, as universities have an obligation to ensure that science improves the socio-economic situation in Africa. They would like to work with the UFS to ensure that science strengthens science in order to serve the people.

“Currently, one of the biggest challenges is the local manufacturing of pharmaceuticals, and that is why we came to the Department of Pharmacology. We need to come together as African universities and use all the existing capacities to transform the lives of our people.”

“African traditional medicine has a lot to offer, and a lot of research has been done, but we have not been able to take it to the level of final commercialisable products. This is the reason of us coming here, we want to create that link to ensure that the science – which has already been identified and established – is able to move to product production,” says Prof Waako.

 

At the right place

They decided to visit the UFS after meeting Prof Matsabisa during his visit to their country’s universities as part of the WHO team.

According to Dr Obakiro, when walking down the corridors of the department, they can see that they are in the right place. “We are also looking at mentorship, as our university is still very young. I am happy and privileged to be here. We cannot succeed on our journey if we do not stand on your shoulders.”

Dr Obakiro said they are also looking at how to set up partnerships between academia and industry, as well as collaboration between the different academic departments, such as pharmacology, chemistry, microbiology, and virology, and how these collaborative initiatives can be effective and efficient to drive their agenda.

In welcoming the colleagues from West Africa, Prof Matsabisa said, “Let’s find a way to crawl together and eventually run together. If you want to move into drug discovery and development, no single scientist can do it alone, it is a multidisciplinary approach. It is a team effort with a shared vision. We have some experience that we can share with you, but we are not perfect, and I think we can learn together.”

News Archive

Researcher part of project aimed at producing third-generation biofuels from microalgae in Germany
2016-05-09

Description: Novagreen bioreactor  Tags: Novagreen bioreactor

Some of the researchers and technicians among the tubes of the Novagreen bioreactor (Prof Grobbelaar on left)

A researcher from the University of the Free State (UFS), Prof Johan Grobbelaar, was invited to join a group of scientists recently at the Institute for Bio- and Geo-Sciences of the Research Centre Jülich, in Germany, where microalgae are used for lipid (oil) production, and then converted to kerosene for the aviation industry.

The project is probably the first of its kind to address bio-fuel production from microalgae on such a large scale.  

“The potential of algae as a fuel source is undisputed, because it was these photoautotrophic micro-organisms that were fixing sunlight energy into lipids for millions of years, generating the petroleum reserves that modern human civilisation uses today.  However, these reserves are finite, so the challenge is marrying biology with technology to produce economically-competitive fuels without harming the environment and compromising our food security.  The fundamental ability that microalgae have to produce energy-rich biomass from CO2, nutrients, and sunlight through photosynthesis for biofuels, is commonly referred to as the Third-Generation Biofuels (3G),” said Prof Grobbelaar.

The key compounds used for bio-diesel and kerosene production are the lipids and, more particularly, the triacylglyserols commonly referred to as TAGs.  These lipids, once extracted, need to be trans-esterified for biodiesel, while a further “cracking” step is required to produce kerosene.  Microalgae can store energy as lipids and/or carbohydrates. However, for biofuels, microalgae with high TAG contents are required.  A number of such algae have been isolated, and lipid contents of up to 60% have been achieved.

According to Prof Grobbelaar, the challenge is large-scale, high-volume production, since it is easy to manipulate growth conditions in the laboratory for experimental purposes.  

The AUFWIND project (AUFWIND, a German term for up-current, or new impetus) in Germany consists of three different commercially-available photobioreactor types, which are being compared for lipid production.

Description: Lipid rich chlorella Tags: Lipid rich chlorella

Manipulated Chlorella with high lipid contents (yellow) in the Novagreen bioreactor

The photobioreactors each occupies 500 m2 of land surface area, are situated next to one another, and can be monitored continuously.  The three systems are from Novagreen, IGV, and Phytolutions.  The Novagreen photobioreactor is housed in a glass house, and consist of interconnected vertical plastic tubes roughly 150 mm in diameter. The Phytolutions system is outdoors, and consists of curtains of vertical plastic tubes with a diameter of about 90 mm.  The most ambitious photobioreactor is from IGV, and consists of horizontally-layered nets housed in a plastic growth hall, where the algae are sprayed over the nets, and allowed to grow while dripping from one net to the next.

Prof Grobbelaar’s main task was to manipulate growth conditions in such a way that the microalgae converted their stored energy into lipids, and to establish protocols to run the various photobioreactors. This was accomplished in just over two months of intensive experimentation, and included modifications to the designs of the photobioreactors, the microalgal strain selection, and the replacement of the nutrient broth with a so-called balanced one.

Prof Grobbelaar has no illusions regarding the economic feasibility of the project.  However, with continued research, optimisation, and utilisation of waste resources, it is highly likely that the first long-haul flights using microalgal-derived kerosene will be possible in the not-too-distant future.

Prof Grobbelaar from the Department of Plant Sciences, although partly retired, still serves on the editorial boards of several journals. He is also involved with the examining of PhDs, many of them from abroad.  In addition, he assisted the Technology Innovation Agency of South Africa in the formulation of an algae-biotechnology and training centre.  “The chances are good that such a centre will be established in Upington, in the Northern Cape,” Prof Grobbelaar said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept